25-Hydroxycholesterol
CAS No. 2140-46-7
25-Hydroxycholesterol ( —— )
产品货号. M19577 CAS No. 2140-46-7
25-Hydroxycholesterol 是一种类固醇衍生物,可抑制甾醇调节元件结合蛋白 (SREBP) 的裂解。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥365 | 有现货 |
|
| 10MG | ¥494 | 有现货 |
|
| 25MG | ¥753 | 有现货 |
|
| 50MG | ¥1150 | 有现货 |
|
| 100MG | ¥1806 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称25-Hydroxycholesterol
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述25-Hydroxycholesterol 是一种类固醇衍生物,可抑制甾醇调节元件结合蛋白 (SREBP) 的裂解。
-
产品描述25-Hydroxycholesterol is a steroid derivative that suppresses the cleavage of sterol regulatory element binding proteins (SREBPs). It inhibits HMG-CoA reductase and so it also plays a significant role in the in vivo regulation of cholesterol biosynthesis after an acute dietary cholesterol challenge. 25-hydroxycholesterol is a potent (EC50≈65 nM) and selective suppressor of IgA production by B cells.
-
体外实验The synthesis of 25-hydroxycholesterol is catalyzed by the enzyme cholesterol 25-hydroxylase, which uses cholesterol and molecular oxygen as substrates and NADPH as a cofactor. 25-hydroxycholesterol is a potent bioactive lipid in the innate and adaptive immune systems.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体other| HMG-CoA Reductase
-
研究领域——
-
适应症——
化学信息
-
CAS Number2140-46-7
-
分子量402.65
-
分子式C27H46O2
-
纯度>98% (HPLC)
-
溶解度Ethanol: 20 mg/mL;Chloroform: 50 mg/mL
-
SMILESC[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.McDonald JG et al. Editorial: 25-Hydroxycholesterol: a new life in immunology. J Leukoc Biol. 2010 Dec;88(6):1071-2.
产品手册
关联产品
-
1,2-Dioleoyl-sn-glyc...
1,2-二油酰-sn-甘油-3-磷酸乙醇胺是阳离子脂质体的中性辅助脂质。它与阳离子磷脂结合使用,可提高 DNA 转染研究中的效率,作为一种非病毒基因传递方法。
-
Sodium Hyaluronate
透明质酸 (HA) 是一种阴离子、非硫酸化糖胺聚糖,广泛分布于结缔组织、上皮组织和神经组织中。它在糖胺聚糖中的独特之处在于它是非硫酸化的,在质膜而不是高尔基体中形成,并且可以非常大,其分子量通常达到数百万。
-
Indolidan
Indolidan (LY 195115) induces cardiovascular and adrenal hyperplastic lesions in Fischer 344 rats. Indolidan increases the risk of cardiovascular disease.
021-51111890
购物车()
sales@molnova.cn

